Camurus Ab Is A Swedish Pharmaceutical And Biotechnology Company Based In Lundspecializing In Innovative Treatments For Severe And Chronic Diseasesfounded In 1991The Company Operates Globally With Over 250 Employees Across 12 Countriesincluding Subsidiaries In The Us And Australiacamurus Is Publicly Traded On Nasdaq Stockholm Under The Tickercamxthe Company Focuses On Addressing Unmet Medical Needs In Areas Such As Central Nervous System Diseasesrare Diseasesendocrine Disordersoncologyand Supportive Careits Proprietary Fluidcrystalatechnology Supports The Development Of Advanced Drug Delivery Systemsincluding Long Acting Depots And Lipid Nanocarrierscamurus Offers Commercial Products Like Buvidalabrixadia Which Are Depot Injections For Opioid Dependence Treatmentand Has A Robust Pipeline Targeting Late Stage Programs In Cns And Rare Diseasesthe Company Collaborates With Global Partners To Enhance Drug Delivery Solutions And Aims To Expand Its Market Presence And R&D Efforts
